Lanean...
Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall?
This commentary offers insight about the recent review by the European Medicines Agency on the approval of daratumumab for the treatment of adult patients with multiple myeloma.
Gorde:
| Argitaratua izan da: | Oncologist |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
AlphaMed Press
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5947460/ https://ncbi.nlm.nih.gov/pubmed/29700211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0097 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|